Drugs / Angiogenic Cell Precursors
Angiogenic Cell Precursors
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00523224 | Jan 2006 → Sep 2007 | congestive heart failure | TheraVitae Ltd. | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01584986 Comparator | May 2008 → Apr 2009 | limb ischemia | Salus Ltd. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | angiogenic cell precursors | “Peripheral blood-derived, ex vivo expanded autologous angiogenic cell precursors (ACPs)” NCT01584986 ↗1“Angiogenic Cell Precursors(ACPs) or Vescell TM” NCT00523224 ↗ |
| Known as | ACPs | “Peripheral blood-derived, ex vivo expanded autologous angiogenic cell precursors (ACPs)” NCT01584986 ↗1“Angiogenic Cell Precursors(ACPs) or Vescell TM” NCT00523224 ↗ |
| Known as | Vescell TM | “Angiogenic Cell Precursors(ACPs) or Vescell TM” NCT00523224 ↗ |
| Modality | Cell therapy | “Stem cells type Angiogenic Cell Precusors(ACPs)” NCT00523224 ↗ |
| Route | Intramuscular | “injected into the ischemic gastrocnemius muscle” NCT01584986 ↗ |